Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Depression |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 9/9/2018 |
| Start Date: | January 5, 2018 |
| End Date: | December 31, 2019 |
The purpose of this study is to determine whether psilocybin-assisted group psychotherapy is
a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).
a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).
This study is an open-label mixed-methods pilot study of an individual oral psilocybin drug
session combined with ten sessions of an evidence-based, manualized brief group psychotherapy
for existential distress in palliative care patients.
session combined with ten sessions of an evidence-based, manualized brief group psychotherapy
for existential distress in palliative care patients.
Inclusion Criterion:
- Older gay-identified men who are long-term AIDS survivors and suffer from
moderate-to-severe demoralization.
Exclusion Criteria:
- A physical, neurological or cognitive condition that makes participating in the study
unsafe or unfeasible.
- Regular psychotropic medication use.
- Personal or family history of serious mental illness.
- Severe depression requiring immediate standard-of-care treatment.
- Exclusion by the clinical judgment of the study investigators.
We found this trial at
1
site
Click here to add this to my saved trials
